Genentech is investigating Columvi as a monotherapy and in combination with other medicines for the treatment of diffuse large B-cell lymphoma and mantle cell lymphoma.

A lymph node biopsy is the main method of diagnosing both non-Hodgkin’s and Hodgkin’s lymphoma, including diffuse large B-cell lymphoma, which is the most common form of non-Hodgkin’s lymphoma.

Sentinel lymph node (SLN) biopsy for early cervical cancer achieved non-inferiority versus pelvic lymphadenectomy, according to results of a large randomized study from China.

Explore diffuse large B-cell lymphoma — symptoms, causes, diagnosis, treatment options, and prevention. Learn about its types, risk factors, and prognosis.

Learn how the late stage of diagnosis that is common with mantle cell lymphoma makes it harder to treat.

Panelists discuss how emerging Bruton tyrosine kinase inhibitor (BTKi) treatment regimens for treatment-naive patients with mantle cell lymphoma (MCL), including acalabrutinib + bendamustine ...

The "sledgehammer-like treatment" of stem cell transplants had no benefit for most mantle cell lymphoma patients, according to study reported at ASH.

Keywords: lymphoma, large-cell, anaplastic, sentinel lymph node biopsy, case report, invasive lobular carcinoma Citation: Kim E (2024) Incidental discovery of invasive lobular carcinoma and anaplastic ...

An expert explained how sentinel lymph node biopsy has helped surgeons remove fewer lymph nodes, which can reduce lymphedema risk in patients with breast cancer.

Mantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatment appears to be successful, the cancer often returns and is difficult to cure. A new therapy ...

As an aside, especially at least in mantle cell lymphoma [MCL], the good thing is while we get a lot of that competitive binding with a 2.5-mg dose because of how fast the body clears obinutuzumab ...